Nuzenio

Xbio

Xbio news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 12 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Xenetic Biosciences Q2 royalty revenue rises on Takeda sublicense - TradingViewTradingView · Fri, 07 Aug 2026 12:44:28 GMT Xenetic Biosciences reports Q2 2026: $0.7M royalty revenue, $0.9M quarterly net loss - TradingViewTradingView · Fri, 07 Aug 2026 12:43:12 GMT Xenetic partner receives Israeli approvals for lymphoma study - Stock TitanStock Titan · Fri, 07 Aug 2026 12:35:00 GMT XBIO 8-K & SEC Filings - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 07:00:00 GMT XBIO 10-Q & SEC Filings - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 01:07:32 GMT Xenetic Biosciences, Inc. 2026: Revenue $660.6K, EPS ($0.41) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:35:07 GMT XBIO Q2 2025 Earnings: Narrower Loss of $0.45 per Share Beats Estimates Despite No Revenue - Earnings Season Preview - dars.gov.etdars.gov.et · Sun, 02 Aug 2026 01:46:38 GMT Xenetic Biosciences Inc. (XBIO) Q2 2025 Earnings: Narrower-than-Expected Loss Highlights Cost Discipline - EPS Surprise History - dars.gov.etdars.gov.et · Thu, 30 Jul 2026 15:44:22 GMT

Timeline

Fri, 07 Aug 2026 12:44:28 GMTXenetic Biosciences Q2 royalty revenue rises on Takeda sublicense - TradingView

Fri, 07 Aug 2026 12:43:12 GMTXenetic Biosciences reports Q2 2026: $0.7M royalty revenue, $0.9M quarterly net loss - TradingView

Fri, 07 Aug 2026 12:35:00 GMTXenetic partner receives Israeli approvals for lymphoma study - Stock Titan

Fri, 07 Aug 2026 07:00:00 GMTXBIO 8-K & SEC Filings - Yahoo Finance

Fri, 07 Aug 2026 01:07:32 GMTXBIO 10-Q & SEC Filings - Yahoo Finance

Thu, 06 Aug 2026 20:35:07 GMTXenetic Biosciences, Inc. 2026: Revenue $660.6K, EPS ($0.41) — 10-Q Summary - TradingView

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Earnings8 live mentions Xenetic Biosciences Inc8 live mentions Inc4 live mentions Narrower4 live mentions Expected Loss Highlights4 live mentions Cost Discipline4 live mentions Xenetic Biosciences3 live mentions TradingView Xenetic Biosciences3 live mentions Takeda2 live mentions TradingView TradingView2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Xbio.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.